The FDA announced on 2017-10-11 that Biomerieux Inc is recalling VITEK2 GP-ID IVD devices due to quality control testing failures. The hazard involves atypical negative O129R reactions for Enterococcus casseliflavus ATCC 700327, causing QC failure in association with three specific lots.
How to tell if you have it
- Brand: Biomerieux
- Product: VITEK2 GP-ID, REF 21342 IVD
- UDI: 03573026131920
- Lot Number: 2420348103
The hazard
Customers have reported, and an internal investigation has confirmed, occurrences of atypical negative O129R reactions for Enterococcus casseliflavus ATCC 700327 in association with three VITEK 2 GP ID lots. This causes failure of the Quality Control (QC) testing for the VITEK 2 GP ID card. The expected O129R reaction for the ATCC 700327 strain is positive according to the Instructions For Use.
Context
GovInfoNow's records show Biomerieux Inc has 36 other recalls on record since 2017-07-12. Other recent recalls of similar products include Biomerieux VITEK 2 AST-N461 Test Kit Recall (2026-07-24), Biomerieux VITEK 2 AST-N447 Kit Recall (2026-06-04), and Biomerieux VITEK 2 Gram-negative Susceptibility Cards May Give False Antibiotic Results (2026-01-05). Other recent recalls of similar products include Meridian Bioscience Revogene C. difficile Test Recall (2025-12-05), HardyDisk AST Cefiderocol 30μg FDC30 (2026-06-08), and BioFire Joint Infection Panel Recall (2026-04-22).